Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.
Droby A, Yoffe-Vasiliev A, Atias D, Fraser KB, Mabrouk OS, Omer N, Bar-Shira A, Gana-Weisz M, Goldstein O, Artzi M, Ben Bashat D, Alcalay RN, Orr-Urtreger A, Shirvan JC, Cedarbaum JM, Giladi N, Mirelman A, Thaler A. Droby A, et al. Among authors: fraser kb. NPJ Parkinsons Dis. 2025 Jan 3;11(1):7. doi: 10.1038/s41531-024-00854-4. NPJ Parkinsons Dis. 2025. PMID: 39753572 Free PMC article.
Novel method for detection of UBE3A protein in CSF from individuals with Angelman syndrome.
Mabrouk OS, Comfort Harris NT, Komorowski RW, Fraser K, Berry-Kravis E, Shen MD, Bird LM, Tan WH, Carson RP, Heimer G, Amaral B, Crean R, Dillon GM, Gilbert JP, Holmberg KH, Zhang H, Hubbard S, Shomo AA, Kapadnis U, Traube-Childs A, Graham DL, Koirala S, Nguyen V. Mabrouk OS, et al. Mol Genet Metab. 2025 Jul;145(3):109132. doi: 10.1016/j.ymgme.2025.109132. Epub 2025 May 2. Mol Genet Metab. 2025. PMID: 40411957
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: fraser kb. Mov Disord. 2022 Mar;37(3):651-652. doi: 10.1002/mds.28929. Epub 2022 Jan 22. Mov Disord. 2022. PMID: 35064687 No abstract available.
Corrigendum to "α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration" [Neurobiol. Dis., Volume 105 (2017) Article 84, 98].
Abdelmotilib H, Maltbie T, Delic V, Liu Z, Hu X, Fraser KB, Moehle MS, Stoyka L, Anabtawi N, Krendelchtchikova V, Volpicelli-Daley LA, West A. Abdelmotilib H, et al. Among authors: fraser kb. Neurobiol Dis. 2021 Nov;159:105506. doi: 10.1016/j.nbd.2021.105506. Epub 2021 Sep 24. Neurobiol Dis. 2021. PMID: 34565675 Free article. No abstract available.
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, Goldstein O, Kestenbaum M, Cedarbaum JM, Mabrouk OS, Fraser KB, Shirvan JC, Orr-Urtreger A, Mirelman A, Thaler A. Omer N, et al. Among authors: fraser kb. Mov Disord. 2022 Jan;37(1):190-195. doi: 10.1002/mds.28792. Epub 2021 Sep 22. Mov Disord. 2022. PMID: 34550621 Free PMC article.
LRRK2 levels in immune cells are increased in Parkinson's disease.
Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, Chang J, Grigoryan N, Factor SA, West AB, Boss JM, Tansey MG. Cook DA, et al. Among authors: fraser kb. NPJ Parkinsons Dis. 2017 Mar 28;3:11. doi: 10.1038/s41531-017-0010-8. eCollection 2017. NPJ Parkinsons Dis. 2017. PMID: 28649611 Free PMC article.
79 results